Vittoria Biotherapeutics, a Philadelphia-based clinical-stage immunotherapy company, showcased preclinical findings at the 66th Annual American Society of Hematology (ASH) Meeting.
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a clinical-stage precision medicine oncology company, announced the nomination of IDE892, a potent and selective …
AI Proteins, Inc., a biotechnology company specializing in the computational design of therapeutic miniproteins, announced a research collaboration and option …
Unnatural Products, Inc. a California-based biotech company specializing in AI-enabled massively parallel chemistry to develop orally bioavailable macrocyclic peptides, announced …
In October 2024, Recursion Pharmaceuticals received FDA clearance to initiate clinical trials for REC-1245, an investigational RBM39 degrader targeting biomarker-enriched …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
